Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Progesterone may help trans women with breast development and health, but more research is needed.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Testosterone treatment may affect heart response to stress in transgender men.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

The healthcare for transgender veterans could be better with a more unified team approach.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.